5.0
18. Juli 2019
Ehemaliger Mitarbeiter, mehr als 10 Jahre
Manila,
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Researched based products where advocacy is patient first. A company that is always 1st to launch in the area of cardiovascular and diabetes brands, oncology and vaccines. Career development of the employee is their top priority and a promise of being the future leader of the company.
Kontras
There is budget cut at times